{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:25:27Z","timestamp":1784150727582,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Academic promotion programme of Shandong First Medical University","award":["2019QL023"],"award-info":[{"award-number":["2019QL023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00330-021-07702-6","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T14:03:32Z","timestamp":1612361012000},"page":"5840-5850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Gadobenate dimeglumine\u2013enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Chenxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuemin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-347X","authenticated-orcid":false,"given":"Xinya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"7702_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","volume":"68","author":"G D'Amico","year":"2018","unstructured":"D'Amico G, Morabito A, D'Amico M et al (2018) Clinical states of cirrhosis and competing risks. J Hepatol 68:563\u2013576","journal-title":"J Hepatol"},{"key":"7702_CR2","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383:1749\u20131761","journal-title":"Lancet"},{"key":"7702_CR3","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/hep.23478","volume":"51","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Friedman S, Iredale J, Pinzani M (2010) Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 51:1445\u20131449","journal-title":"Hepatology"},{"key":"7702_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1365-2036.2010.04473.x","volume":"32","author":"KM Fleming","year":"2010","unstructured":"Fleming KM, Aithal GP, Card TR, West J (2010) The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 32:1343\u20131350","journal-title":"Aliment Pharmacol Ther"},{"key":"7702_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1148\/radiol.2016152800","volume":"282","author":"JH Yoon","year":"2017","unstructured":"Yoon JH, Lee JM, Kim E, Okuaki T, Han JK (2017) Quantitative liver function analysis: volumetric T1 mapping with fast multisection B1 inhomogeneity correction in hepatocyte-specific contrast-enhanced liver MR imaging. Radiology 282:408\u2013417","journal-title":"Radiology"},{"key":"7702_CR6","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.22181","volume":"47","author":"MM Manos","year":"2008","unstructured":"Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP (2008) Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology 47:1150\u20131157","journal-title":"Hepatology"},{"key":"7702_CR7","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","volume":"18","author":"AM Moon","year":"2020","unstructured":"Moon AM, Singal AG, Tapper EB (2020) Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol 18:2650\u20132666","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7702_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","volume":"11","author":"S Singh","year":"2013","unstructured":"Singh S, Fujii LL, Murad MH et al (2013) Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and metaanalysis. Clin Gastroenterol Hepatol 11:1573\u20131584","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7702_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/hep.27389","volume":"60","author":"BK Kim","year":"2014","unstructured":"Kim BK, Kim HS, Yoo EJ et al (2014) Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. Hepatology 60:1911\u20131919","journal-title":"Hepatology"},{"key":"7702_CR10","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WM Rosenberg","year":"2004","unstructured":"Rosenberg WM, Voelker M, Thiel R et al (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127:1704\u20131713","journal-title":"Gastroenterology"},{"key":"7702_CR11","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1053\/j.gastro.2017.03.016","volume":"152","author":"S Singh","year":"2017","unstructured":"Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT (2017) American Gastroenterological Association Institute technical review on the role of elastography in chronic liver diseases. Gastroenterology 152:1544\u20131577","journal-title":"Gastroenterology"},{"key":"7702_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12072-019-09952-5","volume":"13","author":"Y Shen","year":"2019","unstructured":"Shen Y, Wu SD, Wu L et al (2019) The prognostic role of liver stiffness in patients with chronic liver disease: a systematic review and dose-response meta-analysis. Hepatol Int 13:560\u2013572","journal-title":"Hepatol Int"},{"key":"7702_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2013.12.016","volume":"60","author":"SK Asrani","year":"2014","unstructured":"Asrani SK, Talwalkar JA, Kamath PS et al (2014) Role of magnetic resonance elastography in compensated and decompensated liver disease. J Hepatol 60:934\u2013939","journal-title":"J Hepatol"},{"key":"7702_CR14","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00330-017-5278-x","volume":"28","author":"DH Lee","year":"2018","unstructured":"Lee DH, Lee JM, Chang W et al (2018) Prognostic role of liver stiffness measurements using magnetic resonance elastography in patients with compensated chronic liver disease. Eur Radiol 28:3513\u20133521","journal-title":"Eur Radiol"},{"key":"7702_CR15","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cgh.2016.10.041","volume":"15","author":"Y Takuma","year":"2017","unstructured":"Takuma Y, Morimoto Y, Takabatake H, Toshikuni N, Tomokuni J, Sahara A (2017) Measurement of spleen stiffness with acoustic radiation force impulse imaging predicts mortality and hepatic decompensation in patients with liver cirrhosis. Clin Gastroenterol Hepatol 15:1782\u20131790","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7702_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.cgh.2014.07.037","volume":"13","author":"F Nascimbeni","year":"2015","unstructured":"Nascimbeni F, Lebray P, Fedchuk L et al (2015) Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases. Clin Gastroenterol Hepatol 13:763\u2013771","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7702_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nrgastro.2016.86","volume":"13","author":"M Friedrich-Rust","year":"2016","unstructured":"Friedrich-Rust M, Poynard T, Castera L (2016) Critical comparison of elastography methods to assess chronic liver disease. Nat Rev Gastroenterol Hepatol 13:402\u2013411","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7702_CR18","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s00330-018-5932-y","volume":"29","author":"M Bonatti","year":"2019","unstructured":"Bonatti M, Valletta R, Zamboni GA, Lombardo F, Senoner M, Simioni M (2019) Ascites relative enhancement during hepatobiliary phase after Gd-BOPTA administration: a new promising tool for characterising abdominal free fluid of unknown origin. Eur Radiol 29:2830\u20132836","journal-title":"Eur Radiol"},{"key":"7702_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1124\/dmd.118.084624","volume":"47","author":"P Bonnaventure","year":"2019","unstructured":"Bonnaventure P, Cusin F, Pastor CM (2019) Hepatocyte concentrations of imaging compounds associated with transporter inhibition: evidence in perfused rat livers. Drug Metab Dispos 47:412\u2013418","journal-title":"Drug Metab Dispos"},{"key":"7702_CR20","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.3748\/wjg.v23.i17.3133","volume":"23","author":"XM Li","year":"2017","unstructured":"Li XM, Chen Z, Xiao EH, Shang QL, Ma C (2017) Diagnostic value of gadobenate dimeglumine-enhanced hepatocyte-phase magnetic resonance imaging in evaluating hepatic fibrosis and hepatitis. World J Gastroenterol 23:3133\u20133141","journal-title":"World J Gastroenterol"},{"key":"7702_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.mri.2015.03.006","volume":"33","author":"X Zhao","year":"2015","unstructured":"Zhao X, Huang M, Zhu Q, Wang T, Liu Q (2015) The relationship between liver function and liver parenchymal contrast enhancement on Gd-BOPTA-enhanced MR imaging in the hepatocyte phase. Magn Reson Imaging 33:768\u2013773","journal-title":"Magn Reson Imaging"},{"key":"7702_CR22","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1007\/s00330-019-06329-y","volume":"29","author":"K Kozaka","year":"2019","unstructured":"Kozaka K, Kobayashi S, Yoneda N et al (2019) Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features. Eur Radiol 29:6489\u20136498","journal-title":"Eur Radiol"},{"key":"7702_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s00261-016-0693-z","volume":"41","author":"S Lewis","year":"2016","unstructured":"Lewis S, Vasudevan P, Chatterji M et al (2016) Comparison of gadoxetic acid to gadobenate dimeglumine for assessment of biliary anatomy of potential liver donors. Abdom Radiol (NY) 41:1300\u20131309","journal-title":"Abdom Radiol (NY)"},{"key":"7702_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/RLI.0000000000000286","volume":"51","author":"N Bastati","year":"2016","unstructured":"Bastati N, Wibmer A, Tamandl D et al (2016) Assessment of orthotopic liver transplant graft survival on Gadoxetic acid-enhanced magnetic resonance imaging using qualitative and quantitative parameters. Invest Radiol 51:728\u2013734","journal-title":"Invest Radiol"},{"key":"7702_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/bimj.201200045","volume":"55","author":"P Blanche","year":"2013","unstructured":"Blanche P, Dartigues JF, Jacqmin-Gadda H (2013) Review and comparison of ROC curve estimators for a time-dependent outcome with marker-dependent censoring. Biom J 55:687\u2013704","journal-title":"Biom J"},{"key":"7702_CR26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/biom.12107","volume":"70","author":"LE Bantis","year":"2014","unstructured":"Bantis LE, Nakas CT, Reiser B (2014) Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point. Biometrics 70:212\u2013223","journal-title":"Biometrics"},{"key":"7702_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/mrm.27730","volume":"82","author":"FF Mir","year":"2019","unstructured":"Mir FF, Tomaszewski RP, Shuboni-Mulligan DD et al (2019) Chimeric mouse model for MRI contrast agent evaluation. Magn Reson Med 82:387\u2013394","journal-title":"Magn Reson Med"},{"key":"7702_CR28","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00330-014-3291-x","volume":"24","author":"GM Kukuk","year":"2014","unstructured":"Kukuk GM, Schaefer SG, Fimmers R et al (2014) Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests. Eur Radiol 24:2482\u20132490","journal-title":"Eur Radiol"},{"key":"7702_CR29","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.ejrad.2016.09.003","volume":"85","author":"Y Noda","year":"2016","unstructured":"Noda Y, Goshima S, Kajita K et al (2016) Biliary tract enhancement in gadoxetic acid-enhanced MRI correlates with liver function biomarkers. Eur J Radiol 85:2001\u20132007","journal-title":"Eur J Radiol"},{"key":"7702_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1499-3872(12)60165-9","volume":"11","author":"M Okada","year":"2012","unstructured":"Okada M, Ishii K, Numata K et al (2012) Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function? Hepatobiliary Pancreat Dis Int 11:307\u2013313","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"7702_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejrad.2009.08.008","volume":"77","author":"H Takao","year":"2011","unstructured":"Takao H, Akai H, Tajima T et al (2011) MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 77:325\u2013329","journal-title":"Eur J Radiol"},{"key":"7702_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00261-014-0200-3","volume":"40","author":"J Wu","year":"2015","unstructured":"Wu J, Li H, Lin Y, Chen Z, Zhong Q, Gao H (2015) Value of gadoxetate biliary transit time in determining hepatocyte function. Abdom Imaging 40:95\u2013101","journal-title":"Abdom Imaging"},{"key":"7702_CR33","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1007\/s00464-019-07357-x","volume":"34","author":"CH Lin","year":"2020","unstructured":"Lin CH, Ho CM, Wu CH et al (2020) Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma\u2009\u2264\u20092 cm with compensated liver cirrhosis. Surg Endosc 34:5566\u20135573","journal-title":"Surg Endosc"},{"key":"7702_CR34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hep.30857","volume":"71","author":"HSJ Choi","year":"2020","unstructured":"Choi HSJ, Brouwer WP, Zanjir WMR et al (2020) Nonalcoholic steatohepatitis is associated with liver-related outcomes and all-cause mortality in chronic hepatitis B. Hepatology 71:539\u2013548","journal-title":"Hepatology"},{"key":"7702_CR35","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/ajg.2009.191","volume":"104","author":"G Garcia-Tsao","year":"2009","unstructured":"Garcia-Tsao G, Lim JK (2009) Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 104:1802\u20131829","journal-title":"Am J Gastroenterol"},{"key":"7702_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MEG.0000000000000233","volume":"27","author":"S Radcke","year":"2015","unstructured":"Radcke S, Dillon JF, Murray AL (2015) A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. Eur J Gastroenterol Hepatol 27:1\u20137","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7702_CR37","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00330-018-5366-6","volume":"28","author":"K Sandrasegaran","year":"2018","unstructured":"Sandrasegaran K, Cui E, Elkady R et al (2018) Can functional parameters from hepatobiliary phase of gadoxetate MRI predict clinical outcomes in patients with cirrhosis? Eur Radiol 28:4215\u20134224","journal-title":"Eur Radiol"},{"key":"7702_CR38","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1007\/s00330-018-5884-2","volume":"29","author":"C Khouri Chalouhi","year":"2019","unstructured":"Khouri Chalouhi C, Vernuccio F, Rini F et al (2019) Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine. Eur Radiol 29:3090\u20133099","journal-title":"Eur Radiol"},{"key":"7702_CR39","doi-asserted-by":"publisher","first-page":"S975","DOI":"10.1007\/s00330-009-1624-y","volume":"19","author":"A Tanimoto","year":"2009","unstructured":"Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L (2009) Consensus report of the 2nd international forum for liver MRI. Eur Radiol 19:S975\u2013S989","journal-title":"Eur Radiol"},{"key":"7702_CR40","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1007\/s00330-019-06179-8","volume":"29","author":"S Matoori","year":"2019","unstructured":"Matoori S, Froehlich JM, Breitenstein S et al (2019) Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement. Eur Radiol 29:5813\u20135822","journal-title":"Eur Radiol"},{"key":"7702_CR41","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1007\/s00330-016-4674-y","volume":"27","author":"D Geisel","year":"2017","unstructured":"Geisel D, Raabe P, L\u00fcdemann L et al (2017) Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: a prospective trial. Eur Radiol 27:3080\u20133087","journal-title":"Eur Radiol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07702-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-07702-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07702-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T23:07:10Z","timestamp":1674947230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-07702-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["7702"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-07702-6","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"15 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Xinya Zhao.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}